SEC Tracker
Get the app
SRZN · XBRL financial data

Surrozen financial statements, every quarter

The same tables from 12 filings, lined up. Matched by XBRL tag: renamed lines keep their history.

Download Excel Download CSV
How these numbers work
  • Every number comes from the company's XBRL financial data filed with the SEC, and each one links to its filing.
  • Lines are matched by XBRL tag, so a line renamed between filings keeps its history.
  • * marks a quarter worked out from the filing totals: the 10-K year minus the first three quarters, or a year-to-date total minus the earlier one. Fourth-quarter earnings per share is fourth-quarter net income over the fourth-quarter weighted shares.
  • 0 means a filing states zero; a dash (—) means no filing states that number.
  • “year only” means the 10-K gives the full year but not the quarters needed to work out the fourth. A worked-out quarter of revenue, cost of revenue or operating cash flow more than twice the company's largest quarter of the two years before is shown this way too.
  • Gross profit is shown as the company reports it; a worked-out quarter must equal revenue less cost of revenue for that quarter, or it is a dash.
  • Operating income can be above gross profit when the company books other operating income between the two, shown on its own line.
  • Shares outstanding come from each filing's cover page, as of the date printed there.
  • Quarters are fiscal: Q2 FY27 is the second quarter of the company's fiscal 2027.

Income statement

CSV

Fiscal quarters (SRZN's year ends in late December)

In thousands of dollarsSep 30, 2023Dec 31, 2023Mar 31, 2024Jun 30, 2024Sep 30, 2024Dec 31, 2024Mar 31, 2025Jun 30, 2025Sep 30, 2025Dec 31, 2025Mar 31, 2026Jun 30, 2026
Revenue—year only——10,000655*983983983528*5,0005,000
Research and development6,1126,095*5,2475,3355,2005,350*6,5586,0427,7748,991*9,3288,484
General and administrative3,5723,589*3,8833,7143,5683,897*3,9763,9584,0944,176*6,1286,886
Total operating expenses11,1899,724*9,1309,0498,7689,247*10,53410,00011,86813,167*15,45615,370
Operating income (loss)(11,189)(9,724)*(9,130)(9,049)1,232(8,592)*(9,551)(9,017)(10,885)(12,639)*(10,456)(10,370)
Interest income661509*385490431387*2961,025911788*912938
Other income (expense)83302*(85)3,695(3,097)(19,834)*37,98516,218(20,921)(59,594)*(41,106)20,361
Income tax expense (benefit)—year only———year only00—year only00
Net income (loss)(10,445)(8,913)*(8,830)(25,261)(1,434)(28,039)*(26,970)39,746(71,643)(183,159)*(127,505)50,177
Earnings per share, basic USD per share(0.34)—(4.24)(7.99)(0.44)—(7.43)2.55(8.36)—(11.65)2.75
Earnings per share, diluted USD per share(0.34)—(4.24)(7.99)(0.44)—(7.43)2.55(8.36)—(11.65)(0.41)
Weighted average shares, basic thousands of shares30,497—23,1623,228—4999*1111,663
Weighted average shares, diluted thousands of shares30,497—23,1623,228—4999*1123,146

Balance sheet

CSV

Fiscal quarters (SRZN's year ends in late December)

In thousands of dollarsSep 30, 2023Dec 31, 2023Mar 31, 2024Jun 30, 2024Sep 30, 2024Dec 31, 2024Mar 31, 2025Jun 30, 2025Sep 30, 2025Dec 31, 2025Mar 31, 2026Jun 30, 2026
Cash and cash equivalents33,97536,04327,29037,76531,01234,565101,64590,39081,33589,245106,910102,039
Marketable securities9,4570——————————
Accounts receivable1,9782,1522,1282,11212,1962,0392,1302,3172,31705,0005,000
Prepaid and other current assets2,9472,9372,5971,7602,0781,8261,7341,2761,9572,1062,0392,361
Total current assets48,35741,13232,01541,63745,28638,932106,01194,23585,86091,559113,949109,400
Property and equipment, net2,4831,9691,5841,198856562295176139433488456
Right-of-use asset2,3311,8891,5321,1758177,8017,3506,9006,4506,0005,5505,100
Total assets53,97346,08036,71645,07147,99848,467114,829102,69694,04698,726120,709115,606
Accounts payable2875251311732763063023545387288891,073
Accrued liabilities3,9534,1263,4853,6444,3175,1809,0904,1914,7467,9126,7495,950
Total current liabilities6,6727,1486,1795,9836,1207,31510,5825,7436,5289,9309,5659,011
Lease liability, non-current1,527882223006,6406,7786,3165,8385,3494,8514,328
Total liabilities8,4428,1456,58039,00942,33169,847109,15555,582117,561286,488398,856334,271
Accumulated deficit(212,782)(221,695)(230,525)(255,786)(257,220)(285,259)(312,229)(272,483)(344,126)(527,285)(654,790)(604,613)
Total stockholders' equity45,53137,93530,1366,0625,667(21,380)5,67447,114(23,515)(187,762)(278,147)(218,665)
Total liabilities and equity53,97346,08036,71645,07147,99848,467114,829102,69694,04698,726120,709115,606
Common shares outstanding (cover page) thousands of shares30,5753,1993,1993,2063,2503,2818,5638,5708,57111,48711,61011,754

Cash flows

CSV

Fiscal quarters (SRZN's year ends in late December)

In thousands of dollarsSep 30, 2023Dec 31, 2023Mar 31, 2024Jun 30, 2024Sep 30, 2024Dec 31, 2024Mar 31, 2025Jun 30, 2025Sep 30, 2025Dec 31, 2025Mar 31, 2026Jun 30, 2026
Net income (loss)(10,445)(8,913)*(8,830)(25,261)(1,434)(28,039)*(26,970)39,746(71,643)(183,159)*(127,505)50,177
Stock-based compensation913*1,172*1,0301,145*1,039*900*834994*1,005*1,002*2,1052,893*
Net cash from operating activities(10,133)*(7,311)*(8,746)(5,611)*(6,752)*3,481*(9,279)(6,113)*(9,040)*(5,812)*(12,495)(7,415)*
Purchases of property and equipment0*0*70*0*19*2718*24*59*12019*
Net cash from investing activities7,646*9,500*(7)0*0*(19)*(27)(18)*(24)*(59)*(120)(19)*
Proceeds from issuing common stock0*0*016,044*(1)*0*76,386(5,185)*0*3,501*00*
Share repurchases—year only——————————
Net cash from financing activities(13)*141*016,086*(1)*91*76,386(5,124)*9*13,781*30,2802,510*
Net change in cash(2,500)*2,330*(8,753)10,475*(6,753)*3,553*67,080(11,255)*(9,055)*7,910*17,665(4,924)*

Compare with peers

SIC 2836 and related industry codes, similar size. Each row is the latest quarter reported.

How peers are chosen
  • SIC 2836 and related industry codes with public float (or, where float is missing, quarterly revenue) between 0.2x and 5x the company's.
  • Each row is the latest quarter the company has reported, named in the Quarter column; when that filing is a 10-K, it is the fourth quarter, never the full year.
  • Runway shows only for companies burning cash with under $10B of public float.
  • * marks a quarter worked out from the filing totals: for a 10-K, the year less the first three quarters; for a 10-Q, the year-to-date total less the earlier one.
  • A cell reading “not reported” means the filings give no figure for that quarter alone.
CompanyCash ($K)Revenue, quarter ($K)Operating cash flow, quarter ($K)Shares outstandingRunwayQuarter
Surrozen102,0395,000(7,415)*11.8M13.8 quarters 10-QJun 30, 2026
Sutro Biopharma54,3359,839(38,290)*16.6M4.3 quarters 10-QJun 30, 2026
PDS Biotechnology5,596not reported(2,793)*56.0M2.0 quarters 10-QJun 30, 2026
iBio56,3950*(6,228)*64.3M14.1 quarters 10-KJun 30, 2026
Medicinova25,416458(1,920)*49.2M13.2 quarters 10-QJun 30, 2026
Lifevantage14,92042,377*4,767*12.5M— 10-KJun 30, 2026
Veru23,880not reported(5,467)*17.1M4.4 quarters 10-QJun 30, 2026
Whitehawk Therapeutics85,2340(14,529)*57.0M13.1 quarters 10-QJun 30, 2026
Avalo Therapeutics85,382not reported(19,988)*53.6M20.0 quarters 10-QJun 30, 2026

Not investment advice. Not affiliated with the U.S. SEC.